Whether your technology advances planetary stewardship itself or you want to ensure that your product development team will help you to meet ESG targets for your company and investors, Triple Ring integrates sustainability into our entire development process. From supply chain to materials and packaging selection to end-of-life disposal, Triple Ring balances cost, return-on-investment, and risk tolerance to select a design point that serves your needs.
Triple Ring’s Dose Insight tool enables us to recommend radiation sterilization whenever possible. Radiation is a sustainable choice that avoids supply chain disruptions from ethylene oxide (EtO) sterilization plant closures due to environmental concerns. If appropriate for your device, radiation sterilization replaces EtO, which is a carcinogenic pollutant. The tool also enables packaging choices with minimal environmental footprint. The FDA has funded the development of Dose Insight.
— Balancing regulations with sustainable materials
— Ensuring transparency in complex supply chains
— Managing costs of eco-friendly manufacturing
— Reducing carbon footprint without quality trade-offs
Our unique ability to seamlessly integrate assay development with a range of technical disciplines ensures a smooth process.
Access the expertise you need, such as biochemists, molecular biologists, cell biologists, bioengineers, and tech specialists.
From robotics and fluidics to detection systems, we cover all aspects of hardware and assay development.
Our experts possess deep knowledge of disease indications and pathophysiology, ensuring solutions that address the root causes and clinical needs.
Specializing in lab-on-chip and microfluidic technologies, we offer unique solutions that are precisely tailored to your project.
Triple Ring can perform manufacturing of small batches for select projects. While we can work with the manufacturer of our clients’ or collaborators’ choice, we offer preferred manufacturing partners which expedite design for manufacturing (DFM) as well as design transfer. Additionally, we are licensed by the State of California’s Department of Public Health, Food and Drug Branch, to manufacture medical devices for clinical trials.
Triple Ring can perform manufacturing of small batches for select projects. While we can work with the manufacturer of our clients’ or collaborators’ choice, we offer preferred manufacturing partners which expedite design for manufacturing (DFM) as well as design transfer. Additionally, we are licensed by the State of California’s Department of Public Health, Food and Drug Branch, to manufacture medical devices for clinical trials.
Triple Ring can perform manufacturing of small batches for select projects. While we can work with the manufacturer of our clients’ or collaborators’ choice, we offer preferred manufacturing partners which expedite design for manufacturing (DFM) as well as design transfer. Additionally, we are licensed by the State of California’s Department of Public Health, Food and Drug Branch, to manufacture medical devices for clinical trials.
In our experience, understanding the full pathway to FDA approval and manufacturing is crucial to making design decisions at all stages of the development process. What seems like a toss-up decision today can have implications for a significant redesign farther down the road. Working with an experienced development partner mitigates the risks of inadvertent early stage missteps.
Developing new technology is inherently difficult and risky. As a co-development company, we strive to be a trusted partner, not simply a consultant. We structure projects to meet the business needs of our clients, and we often share risk.